Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 5, 2011, Pages 635-643

  Rodriguez Colomo, O ^a,e   Alvarez Lerma F ^b   Gonzalez Perez M I ^c   Sirvent, J M ^d   Garcia Simon M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL DE LEÓN   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LINEZOLID; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; COMMUNICABLE DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; GRAM POSITIVE COCCI; GRAM POSITIVE INFECTION; HOSPITAL INFECTION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SECONDARY INFECTION; SEPSIS; SEPTIC SHOCK; SKIN INFECTION; SOFT TISSUE INFECTION; SURGICAL INFECTION; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CREATININE; CRITICAL ILLNESS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; OXAZOLIDINONES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 79956152100     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-1133-6     Document Type: Article

References (29)

1. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA 302(21):2323-2329
2. Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias. Estudio Nacional de Vigilancia de Infección Nosocomial en Servicios de Medicina Intensiva (ENVIN-UCI). SEMICYUC. http://hws.vhebron.net/envin-helics/ . Accessed 29 February 2010
3. Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F et al (2008) International Nosocomial Infection Control Consortium Members. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control 36:627-637
4. Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, Gómez M, López F (2006) Grupo VIRA. Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2006. Enferm Infecc Microbiol Clín 24:617-628
5. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP (2004) Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 3:14 http://www.ann-clinmicrob.com/content/3/1/14
6. Álvarez Lerma F, Palomar M, Insausti J, Olaechea P, Cerdá E, Sánchez Godoy J, De la Torre MV (2006) Grupo de Estudio Nacional de Vigilancia de Infección Nosocomial en UCI. Staphylococcus aureus nosocomial infections in critically ill patients admitted in intensive care units. Med Clin (Barc) 126:641-646
7. Insausti J (2002) Consumo de antibióticos en medicina intensiva. In: Estudio Nacional de Vigilancia de Infección Nosocomial en UCI (ENVIN-UCI). Jarpyo Editores SA, Madrid, pp 129-148
8. Malacarne P, Rossi C, Bertolini G, GiViTI Group (2004) Antibiotic usage in intensive care units: a pharmacoepidemiological multicentre study. J Antimicrob Chemother 54:221-224 (Pubitemid 39028994)
9. Rodríguez Colomo O, Álvarez Lerma F, Alvarez Sánchez B, Oltra Chordá R, Barcenilla Gaite F, Cereijo Martín-Grande E, de la Hoz Cuñat J, Martínez Pellús A (2008) Study group on the use of active antibiotics against multiresistant gram positive cocci in critical patients. Use of antibiotics for the treatment of multi-resistant gram positive cocci infections in critical patients. Med Intensiva 32:263-271
10. Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH (1990) Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother 25:679-687 (Pubitemid 20167292)
11. Goetz MB, Sayers J (1993) Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination. J Antimicrob Chemother 32:325-334 (Pubitemid 23272318)
12. Ziglam HM, Finch RG (2001) Limitations of presently available glycopeptides in the treatment of Gram-positive infection. Clin Microbiol Infect 7(Suppl 4):53-65 (Pubitemid 34966108)
13. Iwamoto T, Kagawa Y, Kojima M (2003) Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull 26:876-879 (Pubitemid 39655313)
14. Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH (2007) A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther 29:1107-1115 (Pubitemid 47208584)
15. Lodise TP, Lomaestro B, Graves J, Drusano GL (2008) Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 52:1330-1336 (Pubitemid 351521995)
16. Pou L, Rosell M, Lopez R, Pascual C (1996) Changes in vancomycin pharmacokinetics during treatment. Ther Drug Monit 18(2):149-153 (Pubitemid 26102858)
17. Albanèse J, Léone M, Bruguerolle B, Ayem ML, Lacarelle B, Martin C (2000) Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit. Antimicrob Agents Chemother 44(5):1356-1358 (Pubitemid 30228320)
18. Georges H, Leroy O, Alfandari S, Guery B, Roussel-Delvallez M, Dhennain C (1997) Pulmonary disposition of vancomycin in critically ill patients. Eur J Clin Microbiol Infect Dis 16(5):385-388 (Pubitemid 27271829)
19. Lamer C, de Beco V, Soler P, Calvat S, Fagon JY, Dombret MC (1993) Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 37(2):281-286 (Pubitemid 23046569)
20. Daschner FD, Frank U, Kümmel A, Schmidt-Eisenlohr E, Schlosser V, Spillner H (1987) Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery. J Antimicrob Chemother 19(3):359-362 (Pubitemid 17028005)
21. Bingen E, Mariani-Kurkdjian P, Nebbad B (2006) Optimal vancomycin serum level in Staphylococcus aureus infections? Méd Mal Infect 36(9):439-442
22. Wang G, Hindler JF, Ward KW, Bruckner DA (2006) Increased vancomycin MICs for Staphylococcus aureus clinical isolated from a university hospital during a 5-year period. J Clin Microbiol 44:3883-3886 (Pubitemid 44737223)
23. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM (2004) Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42:2398-2402 (Pubitemid 38747480)
24. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46:193-200 (Pubitemid 351269157)
25. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166:2138-2144 (Pubitemid 44631403)
26. Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M et al (2009) Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Am J Health Syst Pharm 66:82-98
27. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13(10):818-829 (Pubitemid 15250137)
29. Bone RC (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874